| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.71B | 24.47B | 24.41B | 24.67B | 24.17B | 23.45B |
| Gross Profit | 14.56B | 16.75B | 16.70B | 16.75B | 16.53B | 16.16B |
| EBITDA | 14.72B | 14.72B | 7.71B | 9.72B | 9.76B | 9.63B |
| Net Income | 6.44B | 6.46B | 344.00M | 2.26B | 2.87B | 2.84B |
Balance Sheet | ||||||
| Total Assets | 81.38B | 80.08B | 73.48B | 71.94B | 69.33B | 66.76B |
| Cash, Cash Equivalents and Short-Term Investments | 1.38B | 320.00M | 1.97B | 1.77B | 149.00M | 289.00M |
| Total Debt | 42.96B | 41.06B | 40.50B | 36.18B | 31.92B | 29.67B |
| Total Liabilities | 57.72B | 56.87B | 56.13B | 51.38B | 46.81B | 43.82B |
| Stockholders Equity | 23.36B | 22.92B | 17.07B | 20.23B | 22.18B | 22.64B |
Cash Flow | ||||||
| Free Cash Flow | 2.76B | 3.29B | 2.56B | 3.18B | 3.23B | 1.09B |
| Operating Cash Flow | 6.57B | 6.99B | 6.99B | 7.95B | 8.37B | 8.01B |
| Investing Cash Flow | -4.17B | -3.60B | -4.44B | -5.78B | -5.52B | -7.00B |
| Financing Cash Flow | -2.19B | -4.65B | -1.75B | -1.54B | -2.99B | -1.02B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | C$12.78B | 13.93 | 35.31% | 2.69% | 0.65% | 15.80% | |
71 Outperform | C$27.37B | 16.49 | 40.28% | 3.94% | 7.44% | 297.46% | |
71 Outperform | C$12.78B | 13.93 | 35.31% | 2.70% | 0.65% | 15.80% | |
67 Neutral | C$30.86B | 12.53 | 31.99% | 7.42% | 1.55% | 1496.64% | |
65 Neutral | C$27.37B | 16.31 | 40.28% | 3.89% | 7.44% | 297.46% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
58 Neutral | C$27.26B | 23.80 | 7.68% | 9.49% | 1.03% | 9.34% |